Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec;172(4):313-331.
doi: 10.1002/ajmg.c.31533. Epub 2016 Nov 14.

Alternative Designs for Clinical Trials in Rare Diseases

Review

Alternative Designs for Clinical Trials in Rare Diseases

Lusine Abrahamyan et al. Am J Med Genet C Semin Med Genet. .

Abstract

Evidence-based medicine requires strong scientific evidence upon which to base treatment. In rare diseases, study populations are often small, and thus this evidence is difficult to accrue. Investigators, though, should be creative and develop a flexible toolkit of methods to deal with the problems inherent in the study of rare disease. This narrative review presents alternative clinical trial designs for studying treatments of rare diseases, including cross-over and n-of-1 trials, randomized placebo-phase design, enriched enrollment, randomized withdrawal design, and classes of adaptive designs. Examples of applications of these designs are presented along with their advantages and disadvantages. Additional analytical considerations such as Bayesian analysis, internal pilots, and use of biomarkers as surrogate outcomes are further discussed. A framework for selecting appropriate clinical trial design is proposed to guide investigators in the process of selecting alternative designs for rare diseases. © 2016 Wiley Periodicals, Inc.

Keywords: Bayes theorem; adaptive trial design; clinical trials; cross-over studies; rare diseases.

Similar articles

See all similar articles

Cited by 14 articles

See all "Cited by" articles

LinkOut - more resources

Feedback